Our Research: Your Experience with T1D & Severe Hypoglycemia
Onlookers might think the scariest parts of living with type 1 diabetes (T1D) are the daily injections and the long-term…
Using Our Methods to Improve Type 2 Diabetes Healthcare
Our work developing and facilitating research that improves care and life with diabetes is no longer limited to type 1…
Managing Type 1 Diabetes with the Flu, Stomach Virus, or Severe Cold
For a person with type 1 diabetes (T1D), everyday illnesses like the flu, a stomach virus, or a severe cold…
Type 1 Diabetes Stem Cell Therapy Gets Greenlight for Human Trials
On March 9, 2023, Vertex Pharmaceuticals received FDA clearance to begin human trials with a new stem cell therapy, VX-264….
What’s New in Dexcom’s G7 Continuous Glucose Monitor
The Dexcom G7 continuous glucose monitor (CGM) received FDA clearance in December 2022 for people with type 1, type 2,…
ATTD 2023 Research: The Impact of Diabetes Tech on Safety & Quality of Life
The 16th international ATTD (Advanced Technology and Treatments for Diabetes) conference was held in Berlin, Germany on February 22-25th. Despite…
Our Research: Your Mental Health with T1D Should Be Part of Routine Healthcare
Editor’s Note: If you are experiencing thoughts of self-harm or suicidal ideation, text the word “NAMI” to the National Alliance…
If You’ve Lived with T1D for 10, 25, 50, or 75 Years…
“Every day with type 1 diabetes is an accomplishment,” says Jeff Hitchcock who founded Children with Diabetes (CWD) after his…
Our Experience: Taking GLP-1 Medications Like Ozempic & Trulicity with Type 1 Diabetes
Tidepool Loop FDA Clearance: Chatting with CEO Howard Look
This week’s FDA clearance of the new Tidepool Loop iPhone app means “looping” could be even simpler and likely far…
